Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)

Name: Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)
Published: 2021
License: Public Domain

Grifols Therapeutics LLC · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

sars-cov-2

covid-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, sars-cov-2, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)

Related documents